The Is My Cancer Different? campaign urges patients to ask their doctors a crucial question ’ is my cancer different? ’ and provides powerful information on why, when and how it could matter to their treatment choices.Presented in video format and featuring cancer survivors, physicians, scientists, advocates and Ronnie Andrews, the president of Clarient, the [...]
[Read more of this report]GE Healthcare signed two new deals that will expand its footprint in the radiotherapy and diagnostics market in China and offer mass spectrometry support in North America.GE signed a memorandum of understanding with Beijing-based Concord Medical Services Holdings Ltd., which operates the largest network of radiotherapy and diagnostic imaging centers in [...]
[Read more of this report]The medical device industry spent more than $20 million on political lobbying in the first quarter of this year.According to filings made to the Lobbying Disclosure Act Database during the first quarter ended March 31, industry giants and small fries spent amounts ranging from $8.6 million (General Electric Co. (NYSE:GE) and all [...]
[Read more of this report]A Minneapolis-based MRI company has been bought by General Electric Healthcare. Steady State Imaging was acquired for an undisclosed amount.SSI is based on the Swift technology developed at the University of Minnesota by which tendons, ligaments and other tissues can be seen during an MRI. That kind of visualization is not available in conventional imaging [...]
[Read more of this report]GE Healthcare landed a $43.2 million contract from the U.S. Dept. of Defense, the federal agency announced.
[Read more of this report]Jeff Kindler, a lawyer tapped as a fresh face to lead drugmaker Pfizer out of its dodrums, is out, after just a little over four years as chairman and chief excutive, reports NPR’s health blog. Kindler’s executive bio already has been erased from Pfizer’s website. Ian C. Read, 57, head of the company’s global biopharmaceuticals operations, is in.
[Read more of this report]Would the Food and Drug Administration advisory committee recommend that the labels of two drugs — dutasteride, made by GlaxoSmithKline and sold as Avodart; and finasteride, a generic made by Merck and sold as Proscar — be changed to say they can reduce a man’s risk of getting prostate cancer? The answer was no, reports the New York Times.
[Read more of this report]MassDevice speaks with GE Healthcare’s eHealth vice president Earl Jones (see podcast link at bottom of story) on how information transparency might help control healthcare costs, improve outcomes and dishes on the politics of healthcare IT.The term “liberated information” may sound like it was taken from a science fiction novel, but to [...]
[Read more of this report]General Electric Co.’s (NYSE:GE) healthcare unit followed up the announcement last week of its half-billion-dollar acquisition of cancer diagnostic company Clarient Inc. (NASDAQ:CLRT) with a new deal to acquire Orbotech Ltd. (NASDAQ:ORBK) subsidiary Orbotech Medical Solutions Ltd.The $9 million cash deal, with up to $5 million in performance-based add-ons, will expand [...]
[Read more of this report]Shareholders of two companies set to be acquired are suing over the offers, alleging that the companies breached their fiduciary duties in agreeing to the buyouts.Investors in AGA Medical Holdings Inc. (NASDAQ:AGAM) sued in the Delaware Chancery Court over St. Jude Medical Inc.’s (NYSE:STJ) $1.3 billion offer for AGA, alleging that “the [...]
[Read more of this report]